Gail L. Kongable
YOU?
Author Swipe
Accuracy of a Novel Noninvasive Transdermal Continuous Glucose Monitor in Critically Ill Patients Open
Background: Stress hyperglycemia and hypoglycemia are associated with increased morbidity and mortality in the critically ill. Intermittent, random blood glucose (BG) measurements can miss episodes of hyper- and hypoglycemia. The purpose o…
Assessing Inpatient Glycemic Control: What are the Next Steps? Open
Despite the emergence of glucometrics (i.e., systematic analysis of data on blood glucose levels of inpatients) as a subject of high interest, there remains a lack of standardization on how glucose parameters are measured and reported. Thi…
Gender Differences in Unruptured Intracranial Aneurysm Formation: Risk Factors and Characteristics Open
P151 The International Study of Unruptured Intracranial Aneurysms (ISUIA) Background and Purpose: There are few data available defining gender-based differences in intracranial aneurysm (UIA) risk factors and occurrence. The ISUIA provides…
Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Open
Early thrombolytic therapy with recombinant tissue-type plasminogen activator is a theoretically attractive approach to the treatment of acute focal cerebral ischemia. In preparation for a larger multicenter trial, three centers piloted a …
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Open
Renewed interest in thrombolytic therapy as potential treatment for patients with acute ischemic stroke prompted a dose-escalation safety study of tissue plasminogen activator in patients with very early (less than or equal to 90 minutes; …